long-term program
I would not have come up on this plan had I not been extremely sick for over two years with multiple myeloma cancer. It was based on the old adage “Necessity is the mother of invention!” Because I was so sick, and in remission from multiple myeloma cancer, I kept thinking that maybe I needed more than just one or two infusions. When I started taking stem cell infusions, in May of 2022, I did so because of glowing reports from people who had very good outcomes. Everybody else looked up upon the infusion as basically a one time event.
As of December, 2024 I have had 23 stem cell infusions for a total of 86 cc. My present plan is to have one 4 cc infusion every month, at least for the next year. I agree that this is plan is very expensive in the short term, but I strongly feel, for me, it is much less expensive long-term. Again, what am I going to do, not spend the money and die a little bit richer?
Why do we need a long-term plan?
Question:
Can infused stem cells from cord blood provide reliable long-term cell division, and if not, how long can they be expected to function effectively without additional replenishment?
ChatGPT:
Cord blood stem cells can provide effective short-term support for blood and immune cell production, typically lasting weeks to a few months without replenishment. However, they are not a reliable source for long-term cell division due to their limited quantity and lack of indefinite self-renewal capacity. They are best used as a temporary measure or as part of a long-term infusion regimen, rather than a standalone solution for sustained regeneration (see INFUSED STEM CELL LIMITATION DETAILS* below).
Question:
Can you tell me the recommended monthly dosage for a person who is 40, 50, 60, 70 or 80? Do this in summary form. (a more detailed discussion will be given later)
ChatGPT:
• Start Low, Adjust as Needed: Begin with 2 cc or 4 cc per month and observe how the individual responds. Adjust based on health outcomes and goals.
• Regular Evaluations: Monitor health markers such as inflammation levels, energy, and overall quality of life to determine if the dosage is effective.
Conclusion
• 40 years old: 2 cc per month for maintenance; 4–6 cc for moderate to severe conditions.
• 50 years old: 2–4 cc per month for general health and moderate concerns; 6 cc for more advanced conditions.
• 60 years old: 4 cc per month for most individuals; 6 cc for aggressive therapy.
• 70 years old: 4 cc per month as a baseline; 6 cc for severe or progressive conditions.
• 80 years old: 4 cc per month minimum; 6 cc for significant therapeutic needs.
Consult a healthcare provider to determine the most appropriate dosage based on individual needs and goals (see STEM CELL DOSAGE DETAiLS** below).
____________________
*INFUSED STEM CELL LIMITATION DETAILS
Infused stem cells from cord blood have remarkable regenerative potential, but they are generally not a reliable source for long-term cell division without replenishment. This limitation is primarily due to their finite quantity and their inability to self-renew indefinitely like a functional bone marrow system.
Timeframe for Operation Without Replenishment
Cord blood stem cells can provide critical support for blood and immune cell production, but their duration of effectiveness depends on several factors:
1. Initial Cell Count: Cord blood typically contains fewer hematopoietic stem cells (HSCs) than other sources like bone marrow or peripheral blood. This lower cell count means that their ability to divide and sustain blood production is inherently time-limited.
2. Engraftment Success: Once infused, cord blood stem cells migrate to the bone marrow and begin dividing. If engraftment is successful, they may support blood and immune cell production for weeks to a few months without further intervention.
3. Depletion Over Time: Because cord blood stem cells do not self-renew indefinitely, their division capacity declines as the cell pool becomes exhausted. This is why they are often used as a temporary measure or bridge to more permanent solutions, such as bone marrow recovery or additional stem cell infusions.
Why Long-Term Reliance Isn’t Feasible
Cord blood stem cells are not designed to function as a sustained, standalone system. They lack the volume and self-renewing capacity required to replace the long-term functionality of bone marrow, which continuously produces fresh stem cells.
Best Use of Cord Blood Stem Cells - Cord blood is most effective when:
• Used in combination with other treatments (e.g., a bone marrow transplant).
• Administered periodically as part of a planned, long-term infusion regimen to maintain regenerative support.
• Employed in situations where short-term regeneration is critical, such as bridging a gap while waiting for another treatment to take effect.
Conclusion
Cord blood stem cells are an excellent short-term solution, providing regenerative benefits for weeks to months, depending on the individual’s condition and treatment strategy. For long-term cell division, a continuous source, such as functional bone marrow or regular infusions, is necessary to sustain blood and immune system health.
____________________
**STEM CELL DOSAGE DETAILS
Question:
Most individuals, who get stem cell therapy, get 1 or 2 infusions at 2cc. Explain the difference and benefits of going on a long-term infusion program.
ChatGPT:
Most individuals who undergo stem cell therapy receive 1 or 2 infusions at 2 cc as a short-term treatment. While these infusions can provide meaningful benefits, a long-term infusion program (e.g., regular monthly infusions) offers significant advantages in terms of sustained health benefits, cumulative effects, and addressing chronic or progressive conditions. Here’s an explanation of the differences and benefits:
1. Short-Term Stem Cell Therapy (1–2 Infusions at 2 cc)
• Purpose:
• Often used as a one-time or trial therapy to provide a temporary boost to the body’s regenerative capacity.
• Commonly sought for acute injuries, minor health improvements, or exploratory treatments.
• Benefits:
• May lead to temporary improvement in inflammation, energy levels, or healing in targeted areas.
• Useful for addressing short-term needs, such as recovery from an injury or surgery.
• Limitations:
• Effects are temporary because the body clears infused stem cells within a few weeks or months.
• No cumulative benefits: Without follow-up infusions, the natural decline of the body’s own stem cells continues, limiting the therapy’s long-term impact.
• Limited scope: May not be sufficient for addressing chronic or widespread degenerative conditions.
2. Long-Term Infusion Program
• Purpose:
• Designed to provide consistent and ongoing support for the body’s regenerative systems.
• Targets long-term health goals, such as slowing aging, managing chronic conditions, or improving overall vitality.
• Structure:
• Monthly or bi-monthly infusions of 2–6 cc, depending on the individual’s needs and goals.
• Regular dosing ensures a steady supply of active stem cells in the body.
• Benefits:
a) Sustained Regeneration and Healing:
• Stem cells promote tissue repair, reduce inflammation, and stimulate regeneration. With regular infusions, these effects are maintained continuously, rather than fading after a single dose.
• Chronic conditions like arthritis, cardiovascular disease, or neurodegeneration benefit from ongoing regenerative support.
b) Cumulative Effects:
• Over time, repeated infusions lead to cumulative improvements in tissue health, immune modulation, and overall function.
• Each infusion builds upon the effects of the previous one, creating a long-term upward trajectory in health.
c) Improved Management of Chronic and Progressive Conditions:
• Conditions such as osteoarthritis, diabetes, or neurodegenerative diseases require ongoing intervention. A long-term program ensures consistent therapeutic effects that slow disease progression.
• It prevents the relapse or rebound that can occur after short-term therapy ends.
d) Support for Aging:
• Aging is associated with a steady decline in the body’s natural stem cell pool and regenerative capacity.
• Regular infusions replenish this pool, helping to combat the effects of aging by supporting repair, reducing inflammation, and improving vitality.
• This is particularly beneficial for individuals over 60, where the natural stem cell count is significantly reduced.
e) Customization and Monitoring:
• A long-term program allows for adjustments to dosage and frequency based on individual response and progress.
• Periodic evaluations ensure the therapy remains effective and aligned with the patient’s evolving needs.
f) Greater Long-Term Impact:
• While short-term treatments may provide a quick boost, long-term programs create lasting improvements in quality of life, energy levels, and overall health outcomes.
Who Should Consider Long-Term Therapy?
• Individuals with Chronic Conditions: Such as arthritis, autoimmune diseases, cardiovascular disease, or neurodegeneration.
• Older Adults (60+): To counteract the natural decline in stem cells and support healthy aging.
• Those Seeking Anti-Aging Benefits: Regular infusions can help maintain vitality, energy, and physical performance.
• People with Significant Tissue Damage: Long-term therapy provides the sustained support needed for extensive healing.
Conclusion
While short-term stem cell therapy can offer temporary benefits, it does not address the ongoing decline in the body’s regenerative capacity or provide cumulative, long-lasting improvements. A long-term infusion program ensures consistent regeneration, cumulative effects, and the ability to manage chronic or progressive conditions effectively. It is particularly valuable for individuals with significant health challenges or those seeking to maintain and improve their health over time.
Question:
Explain why a monthly regimen is better than a bi-monthly or quarterly regimen.
ChatGPT:
A monthly regimen for stem cell infusions is generally better than a bi-monthly (every two months) or quarterly (every three months) regimen due to the following reasons:
1. Consistency of Benefits
• Monthly Infusions: Provide a steady supply of stem cells, ensuring continuous support for tissue repair, regeneration, and inflammation control. This helps maintain more consistent therapeutic effects without significant gaps.
• Bi-monthly or Quarterly Infusions: Result in longer intervals between treatments, leading to fluctuations in benefits. The effects of the infusion may start to wane in the weeks before the next dose, leaving periods of reduced regenerative and anti-inflammatory support.
2. Stem Cell Lifespan
• Infused stem cells typically remain active for a few weeks to a few months, depending on the individual and the condition being treated. With monthly infusions, the body receives new cells before the previous infusion’s effects fully diminish, ensuring sustained regenerative activity.
• In bi-monthly or quarterly regimens, the time between doses may exceed the active lifespan of the stem cells, creating gaps where the benefits are reduced or lost.
3. Anti-inflammatory Effects
• Stem cells modulate the immune system and reduce inflammation. Monthly infusions maintain these effects more consistently, which is crucial for managing chronic conditions or systemic inflammation.
• With less frequent dosing, inflammation may rebound between treatments, potentially reducing the overall effectiveness of the therapy.
4. Cumulative Benefits
• Regular monthly infusions create a cumulative effect, where the ongoing presence of stem cells supports long-term tissue repair and regeneration. This is especially important for age-related conditions, where slow but steady improvements are necessary.
• Less frequent infusions may still provide benefits, but the cumulative effects are slower to build up due to the longer gaps between doses.
5. Faster Progress
• A monthly regimen allows for faster health improvements, especially for individuals managing chronic conditions or significant tissue damage. The body has a more consistent influx of stem cells to address ongoing damage or degeneration.
• Bi-monthly or quarterly regimens may slow progress, as the body receives less frequent boosts of stem cells, extending the time needed to achieve noticeable results.
6. Better for Older Individuals
• At advanced ages (e.g., 70 or 80), natural stem cell levels are severely depleted. Monthly infusions replenish this pool more effectively, helping to counteract the ongoing decline in regenerative capacity.
• Less frequent regimens may not provide enough stem cells to compensate for the body’s natural loss, especially in older individuals.
When Bi-monthly or Quarterly Regimens May Be Considered
• Cost-Effectiveness: Bi-monthly or quarterly dosing may be more affordable, making it a practical option for those with budget constraints.
• Mild Health Concerns: For individuals with mild conditions or those seeking maintenance-level therapy, a less frequent schedule may still offer benefits.
• Convenience: Fewer treatments mean fewer visits, which may be preferable for some individuals.
Conclusion
A monthly regimen provides the most consistent, cumulative, and impactful benefits, particularly for individuals with chronic conditions, significant regenerative needs, or advanced age. While bi-monthly or quarterly regimens can still be effective, they may lead to slower progress and periods of reduced therapeutic effects. Regular monthly dosing ensures steady and continuous support for optimal results.
Question:
Can you tell me the recommended monthly dosage for a person who is 40, 50, 60, 70 or 80?
ChatGPT:
Here’s the recommended monthly dosage of stem cells for individuals aged 40, 50, 60, 70, and 80, considering their natural stem cell levels, health goals, and regenerative needs:
Baseline Stem Cell Levels
• At 40 years old, the body has about 7.5 million stem cells.
• At 50 years old, the body has about 3.9 million stem cells.
• At 60 years old, the body has about 2.31 million stem cells.
• At 70 years old, the body has about 1.5 million stem cells.
• At 80 years old, the body has about 1.08 million stem cells.
• These levels decline steadily with age, reducing the body’s natural ability to repair and regenerate tissues.
Recommended Monthly Dosage
1. Mild Health Concerns or Preventive Care:
• Dosage: 2 cc per month (38 million viable cells).
• Purpose: Maintenance therapy to support general health, slow aging, and provide mild anti-inflammatory benefits.
• Benefits: Helps counteract the natural decline in stem cells, supports moderate tissue repair, and enhances vitality.
• Ages:
• 40 years: Typically sufficient for general health maintenance or mild anti-aging effects.
• 50 years: Effective for maintenance but may need adjustment based on health goals.
• 60 years: Suitable for maintenance-level support but may require higher doses for chronic conditions.
• 70 years: Can provide noticeable benefits but may need 4 cc for stronger effects.
• 80 years: Limited impact due to significant stem cell depletion; 4 cc or more is often recommended.
2. Moderate Health Concerns or Chronic Conditions:
• Dosage: 4 cc per month (76 million viable cells).
• Purpose: Therapeutic support for chronic conditions like arthritis, cardiovascular issues, or moderate neurodegeneration.
• Benefits: Provides stronger anti-inflammatory effects, enhances tissue repair, and improves overall energy and well-being.
• Ages:
• 40 years: Useful for those with mild chronic conditions or early signs of aging.
• 50 years: Ideal for managing moderate health concerns and slowing aging-related decline.
• 60 years: A standard dose for maintaining vitality and managing chronic conditions.
• 70 years: Often the minimum recommended dose to achieve therapeutic effects.
• 80 years: A necessary baseline dose for most individuals to counteract significant stem cell depletion.
3. Severe Health Concerns or Aggressive Regeneration Goals:
• Dosage: 6 cc per month (114 million viable cells).
• Purpose: Intensive therapy for significant tissue damage, chronic inflammation, or severe degenerative conditions.
• Benefits: Provides a stronger and more immediate regenerative boost, with faster and more noticeable improvements.
• Ages:
• 40 years: Generally not required unless addressing severe or unusual conditions.
• 50 years: Effective for individuals managing more advanced chronic conditions.
• 60 years: Suitable for severe conditions requiring aggressive support.
• 70 years: Recommended for aggressive therapeutic goals or severe degenerative issues.
• 80 years: Often the most effective option for those with significant health challenges and low baseline stem cell levels.
Considerations by Age
1. 40 years old: Natural stem cell levels are still relatively high, so 2 cc per month is typically sufficient for maintenance. Higher doses (4–6 cc) can be reserved for individuals with specific health challenges.
2. 50 years old: Stem cell decline becomes more pronounced. 2 cc per month may suffice for general health, but 4 cc is recommended for moderate concerns, with 6 cc for severe conditions.
3. 60 years old: Regenerative capacity is lower, making 4 cc per month the standard dose for most individuals, with 6 cc reserved for significant therapeutic needs.
4. 70 years old: Regeneration slows considerably. 4 cc per month is the baseline for effective therapy, with 6 cc often needed for aggressive therapeutic effects.
5. 80 years old: With stem cell levels most depleted, 4 cc per month is the minimum effective dose, and 6 cc is recommended for substantial therapeutic improvements.
Question:
How often should you reassess the dosage and frequency aspects of your long-term program?
ChatGPT:
It is advisable to reassess the dosage of a stem cell infusion program after about a year, depending on the individual’s progress, health goals, and therapeutic response. Long-term stem cell therapy should be personalized and dynamic, adjusting based on the body’s needs over time. Here’s how and why this reassessment might work:
1. Why Reassess After a Year?
• Health Improvements:
• Over a year of regular infusions, many chronic conditions or degenerative issues may show significant improvement. If symptoms have stabilized or diminished, a lower dosage or reduced frequency might still maintain benefits.
• Cumulative Effects:
• Stem cell therapy often produces cumulative benefits, meaning the body may not require the same intensity of treatment after an extended period of consistent support.
• Adaptation to Therapy:
• The body might become more responsive to treatment over time, requiring less frequent or lower doses to sustain the same therapeutic effects.
• Cost and Convenience:
• Reducing dosage or frequency after achieving a baseline of improved health can make the therapy more sustainable financially and practically.
2. When Should the Dosage Be Reduced?
• If the Health Goals Are Met:
• For example, if inflammation is under control, energy levels are restored, or tissue healing has reached a satisfactory level, reducing the dose may be appropriate.
• If Monitoring Shows Stability:
• Regular lab tests, imaging, or symptom tracking should confirm that the individual’s condition is stable and does not require the same intensity of treatment.
• To Maintain Health:
• After significant improvement, lower dosages can be used for maintenance, preventing regression while minimizing treatment intensity.
3. Possible Adjustments After a Year
• Reduce Dose Per Infusion:
• For example, transition from 4 cc per month to 2 cc per month, maintaining the same monthly frequency but halving the dosage.
• Extend the Interval Between Infusions:
• Shift from monthly infusions (12 per year) to bi-monthly (every 2 months, 6 per year) at the same dosage (e.g., 4 cc).
• Combination of Both:
• Reduce the dosage and the frequency (e.g., 2 cc every 2 months).
4. Risks of Reducing Dosage
• Potential for Relapse:
• If the condition is not fully resolved or still active, reducing the dosage prematurely could lead to a return of symptoms.
• Regular monitoring during the transition is essential to ensure that health improvements are maintained.
• Missed Opportunity for Further Gains:
• In some cases, continuing the same dosage for longer might lead to even greater improvements. The decision to reduce dosage should weigh the potential for further benefits.
5. How to Monitor During Reassessment
• Clinical Markers:
• Track lab results (e.g., inflammatory markers, blood tests, imaging) to ensure stability or continued improvement.
• Symptoms and Quality of Life:
• Regularly evaluate energy levels, pain, mobility, and other key indicators of health.
• Frequency of Follow-Ups:
• Increase the frequency of check-ups during the transition period to quickly identify any signs of regression.
6. Long-Term Maintenance Dosing
After a year of intensive therapy, maintenance dosing might include:
• 2 cc per month for ongoing support.
• 4 cc every 2–3 months for preventive care and to maintain cumulative benefits.
• Adjustments as Needed: Reassess every 6–12 months to ensure the therapy aligns with current health goals.
Conclusion
It is entirely possible to reduce the dosage or frequency of infusions after about a year, especially if significant progress has been made. Regular reassessment and monitoring ensure that the dosage matches the individual’s needs without over- or under-treating. This tailored approach helps balance therapeutic effectiveness, cost, and convenience. Always consult with a healthcare provider to determine the best strategy for dosage adjustment.
____________________
STEM CELL THERAPY, INC.
LEGACY DONORS TO:
MD Anderson, Houston &
Keels & Wheels, Seabrook